Progression Clinical Trial
Official title:
Clinical Trial Comparing Subconjunctival and Topical Bevacizumab as Adjuncts to Trabeculectomy in Improving Outcomes for Primary Open Angle Glaucoma
Bevacizumab is an anti vascular endothelial growth factor(anti-VEGF) substance that is known to reduce neovascularization and fibrovascular proliferation in inflammatory conditions, including post-operative inflammation. It has shown efficacy in numerous ocular conditions(off-label), that includes Age related macular degeneration, proliferative diabetic retinopathy, neovascular glaucoma and corneal neovascularization. It is being explored as an option for preventing recurrence of pterygium and as an adjunct to improving outcomes of trabeculectomy. There is a debate as to the mode and duration of bevacizumab administration for trabeculectomy. This study aims to compare a single subconjunctival dose of bevacizumab with topical therapy over one month in terms of outcomes of trabeculectomy surgery, non-progression of field loss and stable intraocular pressure(IOP) control.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04581122 -
A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components
|
N/A | |
| Recruiting |
NCT03509779 -
Pronostic and Predictive Value of EMT in Localized Lung Cancer
|
||
| Recruiting |
NCT06174324 -
Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation
|
||
| Recruiting |
NCT04422223 -
Prospective Cohort Study of Disease and Outcomes in Cirrhosis
|
||
| Completed |
NCT04682457 -
Defining the Decline in Endogenous Insulin Secretion in Type 1 Diabetes Diagnosed After 30 Years of Age.
|
||
| Recruiting |
NCT03121768 -
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
|
N/A | |
| Completed |
NCT01980212 -
Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer
|
||
| Completed |
NCT05983003 -
Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data
|
||
| Recruiting |
NCT05942456 -
Soluble B7-H3 as a Biomarker for Osteosarcoma
|
||
| Not yet recruiting |
NCT05361772 -
Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial
|
N/A | |
| Recruiting |
NCT03582527 -
PD-L1 Expression in Advanced Osteosarcoma
|
||
| Completed |
NCT01651078 -
Laser Ablation After Stereotactic Radiosurgery
|
||
| Active, not recruiting |
NCT02761070 -
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
|
Phase 3 | |
| Not yet recruiting |
NCT06409416 -
Tumor Cell Plasticity and Aggressiveness in Human Non-small Cell Lung Cancer
|
||
| Not yet recruiting |
NCT05791630 -
The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)
|
N/A | |
| Enrolling by invitation |
NCT03451929 -
Kidney Function and Cardiovascular Events: Cohort Study in General Population
|
N/A | |
| Recruiting |
NCT05153330 -
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
|
Phase 1 | |
| Not yet recruiting |
NCT05184829 -
A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1
|
N/A | |
| Recruiting |
NCT04905056 -
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
|
Phase 2 | |
| Recruiting |
NCT04525833 -
Liver Disease and Other Systemic Diseases
|